Walleye Capital’s Agilon Health AGL Stock Holding History

Walleye Capital’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-563	Closed	-$14.5K	–	4510
2025 Q3	$14.5K	Sell	563 -1,510	-73%	-$57K	﹤0.01%	4244
2025 Q2	$119K	Buy	+2,073	New	+$166K	﹤0.01%	3689
2024 Q4	–	Sell	-8,625	Closed	-$521K	–	4771
2024 Q3	$847K	Buy	8,625 +1,089	+14%	+$141K	﹤0.01%	2817
2024 Q2	$1.23M	Buy	7,536 +7,389	+5,027%	+$1.05M	﹤0.01%	2619
2024 Q1	$22.3K	Sell	147 -103	-41%	-$17.1K	﹤0.01%	4899
2023 Q4	$78.6K	Buy	+250	New	+$90.5K	﹤0.01%	4149
2022 Q1	–	Sell	-664	Closed	-$448K	–	2255
2021 Q4	$448K	Buy	+664	New	+$404K	0.01%	1045

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Walleye Capital's AGL Position: Q4 2025 in Review

Walleye Capital sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 563 shares — an estimated $14.5K sold.

Walleye Capital first reported a position in AGL in Q4 2021 and held it in 7 quarters. The position peaked at $1.23M in Q2 2024. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

Walleye Capital reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
Walleye Capital sold 563 Agilon Health shares in Q4 2025, an estimated $14.5K.
Walleye Capital first reported a position in Agilon Health in Q4 2021 and held it in 7 quarters.
Walleye Capital's Agilon Health position peaked at $1.23M in Q2 2024.
194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.